ACAbraham Carboo

Abraham Carboo

*This is an algorithmically generated author record based on publicly available information.

Abraham Carboo has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    C-Reactive Protein as a Predictor of Cardiovascular Events and Mortality in Obstructive Sleep Apnea: A Propensity-Matched Analysis Using the TriNetX Research Network

    by Ekow Essien, Abena Agyekum, Abraham Carboo, Gloria Amoako, Justice Owusu-Achiaw, Samuel B. Governor

    Obstructive sleep apnea (OSA) increases cardiovascular disease risk through systemic inflammation, particularly through elevated C-reactive protein (CRP). This study investigated whether CRP stratification predicts mortality and cardiovascular events in OSA patients. We conducted a retrospective cohort analysis using the TriNetX Research Network, encompassing electronic health records from 130 healthcare institutions. Adults (ages 18–90 years) with OSA were stratified by CRP concentration: elevated (≥ 3.0 mg/L) versus low (≤ 2.9 mg/L). After propensity score matching for demographics and comorbidities, 240,727 participants per cohort were followed for five years. Primary outcome was all-cause mortality; secondary outcomes included cardiovascular events, arrhythmias, and acute kidney injury. Elevated CRP was associated with significantly higher all-cause mortality (11.3% versus 7.0%; HR 1.695, 95% CI 1.662–1.727; p < 0.001). The elevated CRP group demonstrated heightened cardiovascular risk: cardiogenic shock (1.0% versus 0.5%; HR 2.003), heart failure (9.8% versus 6.5%; HR 1.594), pulmonary hypertension (4.9% versus 3.4%; HR 1.508), and acute kidney injury (11.0% versus 6.4%; HR 1.825), all p < 0.001. Arrhythmic complications were also increased: atrial fibrillation/flutter (6.3% versus 4.8%; HR 1.372) and ventricular tachycardia (2.3% versus 1.8%; HR 1.388), both p < 0.001. Elevated CRP constitutes a robust predictor of mortality and cardiovascular morbidity in OSA populations. Assessment of inflammatory biomarkers may enhance risk stratification, informing intensified monitoring and targeted therapeutic interventions.

  • Open Access

    Comparative Outcomes of Catheter-Directed Thrombectomy Versus Catheter-Directed Thrombolysis in Obese Patients With Pulmonary Embolism: A Propensity-Matched Analysis Using the TriNetX Global Health Research Network

    by Ekow Essien, Abena Agyekum, Abraham Carboo, Gloria Amoako, Karldon Nwaezeapu, Samuel B. Governor, Godbless Ajenaghughrure

    Essien E, et al. J Cardiovasc Interv. 2025 Aug;5:e2. https://doi.org/10.54912/jci.2025.0029


  • Open Access

    Gastroduodenal Artery Pseudoaneurysm, A Rare Cause of Gastrointestinal Bleeding Complicating Pancreatitis

    by Abraham Carboo, Mohammad Ramadan, Patrick Kwaah, Pia Dogbey

    Gastroduodenal artery pseudoaneurysm is an uncommon but life-threatening complication of acute pancreatitis (AP). We present a 58-year-old man with presumed mild AP who developed massive intra-abdominal hemorrhage due to a gastroduodenal artery pseudoaneurysm. The patient's initial imaging suggested a pancreatic pseudocyst, but an atypical presentation for AP prompted a computed tomography angiogram that identified an actively bleeding pseudoaneurysm. He underwent urgent coil embolization with successful hemorrhage control. This case highlights the importance of early recognition and multidisciplinary management of visceral artery pseudoaneurysms in pancreatitis to prevent potentially catastrophic outcomes.


  • Open Access

    Disparities in chronic ischemic heart disease-related mortality across sex, race, and urbanization status in the United States, 1999–2019

    by Patrick A. Kwaah, Samuel A. Mensah, Abraham Carboo, Grace Appah, Hamza A. Rashid, Stephen N. Djanie, Ama O. Kwakye, Emmanuel A. Agyemang, Joseph S. Kekrebesi, Webster Donaldy, et al.

    Chronic ischemic heart disease (CIHD) is one of the leading causes of significant morbidity and mortality in the United States. While previous studies have reported an overall decline in ischemic heart disease mortality, contemporary trends in CIHD-related mortality across sex, race, and urbanization status remain inadequately explored. We examined CIHD-related mortality trends in the U.S. from 1999 to 2019.We analyzed mortality data from the CDC WONDER database using CIHD ICD-10 codes. Age-adjusted mortality rates (AAMR) were calculated per 100,000 individuals. Trends were analyzed using Joinpoint regression to determine annual percentage change (APC) and average annual percentage change (AAPC) with 95% confidence intervals. Over two decades, 5,729,619 CIHD-related deaths were recorded. AAMR declined from 185.6 (95% CI: 184.9–186.2) per 100,000 in 1999 to 94.9 (95% CI: 94.5–95.3) per 100,000 in 2019. There were, however, disparities among demographic groups. Males had consistently higher mortality than females (overall AAMR: 167.2 vs. 96.0 per 100,000), and among racial groups, non-Hispanic Black individuals had the highest AAMR (148.3 per 100,000. Initially, urban areas had higher mortality than rural areas, but by 2019, their AAMRs converged (urban: 94.7 [95% CI: 94.3–95.1]; rural: 96.1 [95% CI: 95.1–97.0] per 100,000). CIHD mortality has declined across all demographics over the last two decades; however, disparities persist, particularly among males and non-Hispanic Black individuals. While rural and urban populations had differing mortality rates initially, they showed similar AAMR by the end of the study period. Focused public health interventions are crucial to addressing these inequities.